Measuring the impact of HIPAA in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

被引：0
|
作者：
Marcus, PM [1 ]
Miedzinksi, M [1 ]
机构：
[1] NCI, Div Canc Prevent, Bethesda, MD 20892 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2005年 / 14卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：549 / 549
页数：1
相关论文
共 50 条
  • [1] Measuring the impact of hipaxs privacy rule in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.
    Marcus, PM
    Miedzinksi, M
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (11) : S151 - S151
  • [2] The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial - Preface
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 249S - 250S
  • [3] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Prorok, PC
    Andriole, GL
    Bresalier, RS
    Buys, SS
    Chia, D
    Crawford, ED
    Fogel, R
    Gelmann, EP
    Gilbert, F
    Hasson, MA
    Hayes, RB
    Johnson, CC
    Mandel, JS
    Oberman, A
    O'Brien, B
    Oken, MM
    Rafla, S
    Reding, D
    Rutt, W
    Weissfeld, JL
    Yokochi, L
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 273S - 309S
  • [4] Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Hu, Ping
    Oken, Martin M.
    Winslow, Stephen D.
    Kvale, Paul A.
    Prorok, Philip C.
    Ragard, Lawrence R.
    Commins, John
    Lynch, David A.
    Andriole, Gerald L.
    Buys, Saundra S.
    Fouad, Mona N.
    Fuhrman, Carl R.
    Isaacs, Claudine
    Yokochi, Lance A.
    Riley, Thomas L.
    Pinsky, Paul F.
    Gohagan, John K.
    Berg, Christine D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10) : 722 - 731
  • [5] Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Stallings, FL
    Ford, ME
    Simpson, NK
    Fouad, M
    Jernigan, JC
    Trauth, JM
    Miller, DS
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 379S - 389S
  • [6] Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Black, Amanda
    Parnes, Howard L.
    Grubb, Robert
    Crawford, E. David
    Miller, Anthony
    Reding, Douglas
    Andriole, Gerald
    [J]. CANCER EPIDEMIOLOGY, 2012, 36 (06) : E401 - E406
  • [7] Impact of PSA screening on mortality - PLCO Project Team (Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial)
    Heidenreich, A.
    Nitschmann, S.
    [J]. INTERNIST, 2010, 51 (02): : 219 - 220
  • [8] Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial
    Miller, Eric A.
    Pinsky, Paul F.
    Black, Amanda
    Andriole, Gerald L.
    Pierre-Victor, Dudith
    [J]. PROSTATE, 2018, 78 (11): : 830 - 838
  • [9] Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Miller, Anthony B.
    Feld, Ronald
    Fontana, Robert
    Gohagan, John K.
    Jatoi, Ismail
    Lawrence, Walter, Jr.
    Miller, Amy
    Prorok, Philip C.
    Rajput, Ashwani
    Sherman, Morris
    Welch, Gilbert
    Wright, Patrick
    Yurgalevitch, Susan
    Albertsen, Peter
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2015, 10 (03) : 206 - 211
  • [10] Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Miller, AB
    Yurgalevitch, S
    Weissfeld, JL
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 400S - 406S
12345